Blood Journal
Leading the way in experimental and clinical research in hematology

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDS)

This article is only available in PDF format. Please click on the PDF button to view this article.

This is a PDF-only article. The first page of the PDF of this article appears below.

PDF extract preview